» Articles » PMID: 8257637

The Effect of Age on the Course of Experimental Feline Immunodeficiency Virus Infection in Cats

Overview
Publisher Mary Ann Liebert
Date 1993 Sep 1
PMID 8257637
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Neonatal, young adult, and aged specific pathogen-free cats were experimentally infected with cat-passaged Petaluma strain of feline immunodeficiency virus. The primary stage of illness occurred 6-8 weeks following infection in cats of all ages, but it differed in severity and clinical signs. Generalized lymphadenopathy persisted for the entire 42-week study period in neonatally infected cats, was transient in young adults, but inapparent in aged cats. Only two aged cats became chronically and severely ill during the study. One aged cat died with severe necrotizing transmural enteritis, while a second developed chronic generalized staphylococcal pyoderma that was partially controlled with antibiotics. Neutropenia appeared 6-8 weeks following infection in cats of all ages, but was more severe in newborn and aged cats than in young adults. A persistent decrease in CD4+/CD8+ T lymphocyte ratios, due to both increased CD8+ and decreased CD4+ T lymphocytes, occurred in the neonatal and aged cats. Decreased CD4+/CD8+ T lymphocyte ratios in the young adult cats was due solely to decreased CD4+ T lymphocytes. Antibody response to FIV virus, as measured by ELISA to recombinant FIV p24 antigen, was lower in aged cats than the other age groups during the first 6 weeks after infection. Antibody levels were not significantly different among the three age groups thereafter. Although there are some differences between FIV infection of cats and HIV infection of human beings, age at infection influences the severity of disease in both species.

Citing Articles

Contrasting clinical outcomes in two cohorts of cats naturally infected with feline immunodeficiency virus (FIV).

Beczkowski P, Litster A, Long Lin T, Mellor D, Willett B, Hosie M Vet Microbiol. 2015; 176(1-2):50-60.

PMID: 25595267 PMC: 4332694. DOI: 10.1016/j.vetmic.2014.12.023.


Prevalence of feline immunodeficiency virus and feline leukaemia virus among client-owned cats and risk factors for infection in Germany.

Gleich S, Krieger S, Hartmann K J Feline Med Surg. 2009; 11(12):985-92.

PMID: 19616984 PMC: 11318771. DOI: 10.1016/j.jfms.2009.05.019.


Feline immunodeficiency. ABCD guidelines on prevention and management.

Hosie M, Addie D, Belak S, Boucraut-Baralon C, Egberink H, Frymus T J Feline Med Surg. 2009; 11(7):575-84.

PMID: 19481037 PMC: 7129779. DOI: 10.1016/j.jfms.2009.05.006.


Vaccination with vif-deleted feline immunodeficiency virus provirus, GM-CSF, and TNF-alpha plasmids preserves global CD4 T lymphocyte function after challenge with FIV.

Maksaereekul S, Dubie R, Shen X, Kieu H, Dean G, Sparger E Vaccine. 2009; 27(28):3754-65.

PMID: 19464559 PMC: 2802579. DOI: 10.1016/j.vaccine.2009.03.081.


A novel method for producing target cells and assessing cytotoxic T lymphocyte activity in outbred hosts.

Bonci F, Zabogli E, Conti F, Merico A, Freer G, Bendinelli M BMC Biotechnol. 2009; 9:18.

PMID: 19284578 PMC: 2662824. DOI: 10.1186/1472-6750-9-18.